Kolexia
Moise Laura Oncologie médicale
Moise Laura
Oncologie médicale
Cabinet libéral
Saint-Martin-des-Champs, France
41 Activités
96 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Carcinomes Néphrocarcinome Tumeurs prostatiques résistantes à la castration Sarcomes Tumeurs du système nerveux central Chordome Métastase tumorale Carcinome adénoïde kystique

Collaborateurs

Voir plus
Allouache Nedjla
Allouache Nedjla
Centre François-Baclesse, Caen, France
Coquan Elodie
Coquan Elodie
Centre François-Baclesse, Caen, France
Meyer Emmanuel
Meyer Emmanuel
Cabinet libéral, Caen, France
Meriaux Emeline
Meriaux Emeline
Centre François-Baclesse, Caen, France

Industries

Voir plus
Ipsen
11 collaboration(s)
Dernière en 2023
A+A
6 collaboration(s)
Dernière en 2022
Janssen
6 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).
European journal of cancer (Oxford, England : 1990)   04 octobre 2021
ETOILE: Transnational Randomized Study Comparing Carbon Ions Therapy Versus Conventional Radiotherapy - Including Protontherapy - for the Treatment of Radioresistant Tumors
Essai Clinique (Hospices Civils de Lyon)   01 septembre 2021
Outcomes of patients with metastatic castration resistant prostate cancer according to somatic sequencing of domage DNA repair genes.
2020 ASCO Annual Meeting I   25 mai 2020
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
International journal of cancer   01 août 2019
Predictive factors of F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?
EJNMMI research   21 novembre 2016
Everolimus and sunitinib as first- and second-line treatments of patients with metastatic papillary renal cell carcinoma (pRCC): A retrospective study of the GETUG (Groupe Français d’Etude des Tumeurs Uro-Génitales).
2016 Genitourinary Cancers Symposium   10 janvier 2016
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
BMC cancer   04 avril 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use program in France.
2015 Genitourinary Cancers Symposium   01 mars 2015
Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
Leukemia & lymphoma   06 décembre 2010
Influence of vascular endothelial growth factor (VEGF) single nucleotide polymorphisms (SNPs) on prognosis of glioblastoma (GB) patients.
2010 ASCO Annual Meeting I   20 mai 2010